Skip to main content
Erschienen in: Calcified Tissue International 2/2019

10.10.2018 | Original Research

Assessing the Genetic Correlations Between Blood Plasma Proteins and Osteoporosis: A Polygenic Risk Score Analysis

verfasst von: Xiao Liang, Yanan Du, Yan Wen, Li Liu, Ping Li, Yan Zhao, Miao Ding, Bolun Cheng, Shiqiang Cheng, Mei Ma, Lu Zhang, Hui Shen, Qing Tian, Xiong Guo, Feng Zhang, Hong-Wen Deng

Erschienen in: Calcified Tissue International | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Osteoporosis is a common metabolic bone disease. The impact of global blood plasma proteins on the risk of osteoporosis remains elusive now. We performed a large-scale polygenic risk score (PRS) analysis to evaluate the potential effects of blood plasma proteins on the development of osteoporosis in 2286 Caucasians, including 558 males and 1728 females. Bone mineral density (BMD) and bone areas at ulna & radius, hip, and spine were measured using Hologic 4500W DXA. BMD/bone areas values were adjusted for age, sex, height, and weight as covariates. Genome-wide SNP genotyping of 2286 Caucasian subjects was performed using Affymetrix Human SNP Array 6.0. The 267 blood plasma proteins-associated SNP loci and their genetic effects were obtained from recently published genome-wide association study (GWAS) using a highly multiplexed aptamer-based affinity proteomics platform. The polygenetic risk score (PRS) of study subjects for each blood plasma protein was calculated from the genotypes data of the 2286 Caucasian subjects by PLINK software. Pearson correlation analysis of individual PRS values and BMD/bone area value was performed using R. Additionally, gender-specific analysis also was performed by Pearson correlation analysis. 267 blood plasma proteins were analyzed in this study. For BMD, we observed association signals between 41 proteins and BMD, mainly including whole body total BMD versus Factor H (p value = 9.00 × 10−3), whole body total BMD versus BGH3 (p value = 1.40 × 10−2), spine total BMD versus IGF-I (p value = 2.15 × 10−2), and spine total BMD versus SAP (p value = 3.90 × 10−2). As for bone areas, association evidence was observed between 45 blood plasma proteins and bone areas, such as ferritin versus spine area (p value = 1.90 × 10−2), C4 versus hip area (p value = 1.25 × 10−2), and hemoglobin versus right ulna and radius area (p value = 2.70 × 10−2). Our study results suggest the modest impact of blood plasma proteins on the variations of BMD/bone areas, and identify several candidate blood plasma proteins for osteoporosis.
Literatur
1.
Zurück zum Zitat Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements—an overview. J Trace Elements Med Biol 26:149–152CrossRef Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements—an overview. J Trace Elements Med Biol 26:149–152CrossRef
2.
Zurück zum Zitat Yang T-L, Guo Y, Li J, Zhang L, Shen H, Li SM, Li SK, Tian Q, Liu Y-J, Papasian CJ, Deng H-W (2013) Gene–gene interaction between RBMS3 and ZNF516 influences bone mineral density. J Bone Miner Res 28:828–837CrossRefPubMedCentralPubMed Yang T-L, Guo Y, Li J, Zhang L, Shen H, Li SM, Li SK, Tian Q, Liu Y-J, Papasian CJ, Deng H-W (2013) Gene–gene interaction between RBMS3 and ZNF516 influences bone mineral density. J Bone Miner Res 28:828–837CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Velázquezcruz R, Jiménezortega RF, Parratorres AY, Castillejoslópez M, Patiño N, Quiterio M, Villarrealmolina T, Salmerón J (2014) Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women. BMC Musculoskel Disord 15:400CrossRef Velázquezcruz R, Jiménezortega RF, Parratorres AY, Castillejoslópez M, Patiño N, Quiterio M, Villarrealmolina T, Salmerón J (2014) Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women. BMC Musculoskel Disord 15:400CrossRef
4.
Zurück zum Zitat Sassi R, Sahli H, Souissi C, El Mahmoudi H, Zouari B, ElGaaied ABA, Sellami S, Ferrari SL (2014) Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women. BMC Musculoskel Disord 15:144–144CrossRef Sassi R, Sahli H, Souissi C, El Mahmoudi H, Zouari B, ElGaaied ABA, Sellami S, Ferrari SL (2014) Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women. BMC Musculoskel Disord 15:144–144CrossRef
5.
Zurück zum Zitat Deng FY, Lei SF, Zhang Y, Zhang YL, Zheng YP, Zhang LS, Pan R, Wang L, Tian Q, Shen H, Zhao M, Lundberg YW, Liu YZ, Papasian CJ, Deng HW (2011) Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol Cell Proteomics 10:M111.011700CrossRefPubMedCentralPubMed Deng FY, Lei SF, Zhang Y, Zhang YL, Zheng YP, Zhang LS, Pan R, Wang L, Tian Q, Shen H, Zhao M, Lundberg YW, Liu YZ, Papasian CJ, Deng HW (2011) Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol Cell Proteomics 10:M111.011700CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Chupeerach C, Harnroongroj T, Phonrat B, Tungtrongchitr A, Schweigert FJ, Tungtrongchitr R, Preutthipan S (2011) Decreased retinol transport proteins in Thai post-menopausal women with osteoporosis. Southeast Asian J Trop Med Public Health 42:1515–1520PubMed Chupeerach C, Harnroongroj T, Phonrat B, Tungtrongchitr A, Schweigert FJ, Tungtrongchitr R, Preutthipan S (2011) Decreased retinol transport proteins in Thai post-menopausal women with osteoporosis. Southeast Asian J Trop Med Public Health 42:1515–1520PubMed
7.
Zurück zum Zitat Qundos U, Drobin K, Mattsson C, Hong MG, Sjoberg R, Forsstrom B, Solomon D, Uhlen M, Nilsson P, Michaelsson K, Schwenk JM (2016) Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients. Proteomics Clin Appl 10:681–690CrossRefPubMed Qundos U, Drobin K, Mattsson C, Hong MG, Sjoberg R, Forsstrom B, Solomon D, Uhlen M, Nilsson P, Michaelsson K, Schwenk JM (2016) Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients. Proteomics Clin Appl 10:681–690CrossRefPubMed
8.
Zurück zum Zitat Wu Q, Zhong ZM, Pan Y, Zeng JH, Zheng S, Zhu SY, Chen JT (2015) Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis. Med Sci Monit Int Med J Exp Clin Res 21:2428–2432 Wu Q, Zhong ZM, Pan Y, Zeng JH, Zheng S, Zhu SY, Chen JT (2015) Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis. Med Sci Monit Int Med J Exp Clin Res 21:2428–2432
9.
Zurück zum Zitat Horne BD, Anderson JL, Carlquist JF, Muhlestein JB, Renlund DG, Bair TL, Pearson RR, Camp NJ (2005) Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet 69:176–186CrossRefPubMedCentralPubMed Horne BD, Anderson JL, Carlquist JF, Muhlestein JB, Renlund DG, Bair TL, Pearson RR, Camp NJ (2005) Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet 69:176–186CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Kawai VK, Levinson RT, Adefurin A, Kurnik D, Collier SP, Conway D, Stein CM (2017) A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes. Clin Endocrinol 87:149–155CrossRef Kawai VK, Levinson RT, Adefurin A, Kurnik D, Collier SP, Conway D, Stein CM (2017) A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes. Clin Endocrinol 87:149–155CrossRef
11.
Zurück zum Zitat Belsky DW, Moffitt TE, Sugden K, Williams B, Houts R, Mccarthy J, Caspi A (2013) Development and evaluation of a genetic risk score for obesity. Biodemogr Soc Biol 59:85–100CrossRef Belsky DW, Moffitt TE, Sugden K, Williams B, Houts R, Mccarthy J, Caspi A (2013) Development and evaluation of a genetic risk score for obesity. Biodemogr Soc Biol 59:85–100CrossRef
12.
Zurück zum Zitat Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, Sharma A, Guiducci C, Perola M, Jula A, Sinisalo J, Lokki ML, Nieminen MS, Melander O, Salomaa V, Peltonen L, Kathiresan S (2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376:1393–1400CrossRefPubMedCentralPubMed Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, Sharma A, Guiducci C, Perola M, Jula A, Sinisalo J, Lokki ML, Nieminen MS, Melander O, Salomaa V, Peltonen L, Kathiresan S (2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 376:1393–1400CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4:7CrossRefPubMedCentralPubMed Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4:7CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Zheng HF, Forgetta V, Hsu YH, Estrada K, Rosello-Diez A, Leo PJ, Dahia CL, Park-Min KH, Tobias JH, Kooperberg C, Kleinman A, Styrkarsdottir U, Liu CT, Uggla C, Evans DS, Nielson CM, Walter K, Pettersson-Kymmer U, McCarthy S, Eriksson J, Kwan T, Jhamai M, Trajanoska K, Memari Y, Min J, Huang J, Danecek P, Wilmot B, Li R, Chou WC, Mokry LE, Moayyeri A, Claussnitzer M, Cheng CH, Cheung W, Medina-Gomez C, Ge B, Chen SH, Choi K, Oei L, Fraser J, Kraaij R, Hibbs MA, Gregson CL, Paquette D, Hofman A, Wibom C, Tranah GJ, Marshall M, Gardiner BB, Cremin K, Auer P, Hsu L, Ring S, Tung JY, Thorleifsson G, Enneman AW, van Schoor NM, de Groot LC, van der Velde N, Melin B, Kemp JP, Christiansen C, Sayers A, Zhou Y, Calderari S, van Rooij J, Carlson C, Peters U, Berlivet S, Dostie J, Uitterlinden AG, Williams SR, Farber C, Grinberg D, LaCroix AZ, Haessler J, Chasman DI, Giulianini F, Rose LM, Ridker PM, Eisman JA, Nguyen TV, Center JR, Nogues X, Garcia-Giralt N, Launer LL, Gudnason V, Mellstrom D, Vandenput L, Amin N, van Duijn CM, Karlsson MK, Ljunggren O, Svensson O, Hallmans G, Rousseau F, Giroux S, Bussiere J, Arp PP et al (2015) Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature 526:112–117CrossRefPubMedCentralPubMed Zheng HF, Forgetta V, Hsu YH, Estrada K, Rosello-Diez A, Leo PJ, Dahia CL, Park-Min KH, Tobias JH, Kooperberg C, Kleinman A, Styrkarsdottir U, Liu CT, Uggla C, Evans DS, Nielson CM, Walter K, Pettersson-Kymmer U, McCarthy S, Eriksson J, Kwan T, Jhamai M, Trajanoska K, Memari Y, Min J, Huang J, Danecek P, Wilmot B, Li R, Chou WC, Mokry LE, Moayyeri A, Claussnitzer M, Cheng CH, Cheung W, Medina-Gomez C, Ge B, Chen SH, Choi K, Oei L, Fraser J, Kraaij R, Hibbs MA, Gregson CL, Paquette D, Hofman A, Wibom C, Tranah GJ, Marshall M, Gardiner BB, Cremin K, Auer P, Hsu L, Ring S, Tung JY, Thorleifsson G, Enneman AW, van Schoor NM, de Groot LC, van der Velde N, Melin B, Kemp JP, Christiansen C, Sayers A, Zhou Y, Calderari S, van Rooij J, Carlson C, Peters U, Berlivet S, Dostie J, Uitterlinden AG, Williams SR, Farber C, Grinberg D, LaCroix AZ, Haessler J, Chasman DI, Giulianini F, Rose LM, Ridker PM, Eisman JA, Nguyen TV, Center JR, Nogues X, Garcia-Giralt N, Launer LL, Gudnason V, Mellstrom D, Vandenput L, Amin N, van Duijn CM, Karlsson MK, Ljunggren O, Svensson O, Hallmans G, Rousseau F, Giroux S, Bussiere J, Arp PP et al (2015) Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature 526:112–117CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575CrossRefPubMedCentralPubMed Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Reinboth B, Thomas J, Hanssen E, Gibson MA (2006) Beta ig-h3 interacts directly with biglycan and decorin, promotes collagen VI aggregation, and participates in ternary complexing with these macromolecules. J Biol Chem 281:7816–7824CrossRefPubMed Reinboth B, Thomas J, Hanssen E, Gibson MA (2006) Beta ig-h3 interacts directly with biglycan and decorin, promotes collagen VI aggregation, and participates in ternary complexing with these macromolecules. J Biol Chem 281:7816–7824CrossRefPubMed
18.
Zurück zum Zitat Ohno S, Doi T, Tsutsumi S, Okada Y, Yoneno K, Kato Y, Tanne K (2002) RGD-CAP ((beta)ig-h3) is expressed in precartilage condensation and in prehypertrophic chondrocytes during cartilage development. Biochim et Biophys Acta 1572:114–122CrossRef Ohno S, Doi T, Tsutsumi S, Okada Y, Yoneno K, Kato Y, Tanne K (2002) RGD-CAP ((beta)ig-h3) is expressed in precartilage condensation and in prehypertrophic chondrocytes during cartilage development. Biochim et Biophys Acta 1572:114–122CrossRef
19.
Zurück zum Zitat Han MS, Kim JE, Shin HI, Kim IS (2008) Expression patterns of betaig-h3 in chondrocyte differentiation during endochondral ossification. Exp Mol Med 40:453–460CrossRefPubMedCentralPubMed Han MS, Kim JE, Shin HI, Kim IS (2008) Expression patterns of betaig-h3 in chondrocyte differentiation during endochondral ossification. Exp Mol Med 40:453–460CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Ohno S, Doi T, Fujimoto K, Ijuin C, Tanaka N, Tanimoto K, Honda K, Nakahara M, Kato Y, Tanne K (2002) RGD-CAP (betaig-h3) exerts a negative regulatory function on mineralization in the human periodontal ligament. J Dent Res 81:822–825CrossRefPubMed Ohno S, Doi T, Fujimoto K, Ijuin C, Tanaka N, Tanimoto K, Honda K, Nakahara M, Kato Y, Tanne K (2002) RGD-CAP (betaig-h3) exerts a negative regulatory function on mineralization in the human periodontal ligament. J Dent Res 81:822–825CrossRefPubMed
21.
Zurück zum Zitat Yu H, Wergedal JE, Zhao Y, Mohan S (2012) Targeted disruption of TGFBI in mice reveals its role in regulating bone mass and bone size through periosteal bone formation. Calcif Tissue Int 91:81–87CrossRefPubMed Yu H, Wergedal JE, Zhao Y, Mohan S (2012) Targeted disruption of TGFBI in mice reveals its role in regulating bone mass and bone size through periosteal bone formation. Calcif Tissue Int 91:81–87CrossRefPubMed
22.
Zurück zum Zitat Ahn SH, Lee S, Kim H, Lee SH, Kim BJ, Koh JM (2016) Higher serum ferritin level and lower femur neck strength in women at the stage of bone loss (≥ 45 years of age): the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Endocr Res 41:334–342CrossRefPubMed Ahn SH, Lee S, Kim H, Lee SH, Kim BJ, Koh JM (2016) Higher serum ferritin level and lower femur neck strength in women at the stage of bone loss (≥ 45 years of age): the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Endocr Res 41:334–342CrossRefPubMed
23.
Zurück zum Zitat Sarrai M, Duroseau H, D’Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136:666–672CrossRefPubMed Sarrai M, Duroseau H, D’Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136:666–672CrossRefPubMed
24.
Zurück zum Zitat Chon SJ, Choi YR, Roh YH, Yun BH, Cho S, Choi YS, Lee BS, Seo SK (2014) Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008–2010. PloS ONE 9:e114972CrossRefPubMedCentralPubMed Chon SJ, Choi YR, Roh YH, Yun BH, Cho S, Choi YS, Lee BS, Seo SK (2014) Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008–2010. PloS ONE 9:e114972CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Lee KS, Jang JS, Lee DR, Kim YH, Nam GE, Han BD, Do Han K, Cho KH, Kim SM, Choi YS, Kim DH (2014) Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008–2010 Korea National Health and Nutrition Examination Surveys. J Bone Miner Metab 32:683–690CrossRefPubMed Lee KS, Jang JS, Lee DR, Kim YH, Nam GE, Han BD, Do Han K, Cho KH, Kim SM, Choi YS, Kim DH (2014) Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008–2010 Korea National Health and Nutrition Examination Surveys. J Bone Miner Metab 32:683–690CrossRefPubMed
26.
Zurück zum Zitat Heidari B, Hosseini R, Javadian Y, Bijani A, Sateri MH, Nouroddini HG (2015) Factors affecting bone mineral density in postmenopausal women. Arch Osteoporos 10:1–7CrossRef Heidari B, Hosseini R, Javadian Y, Bijani A, Sateri MH, Nouroddini HG (2015) Factors affecting bone mineral density in postmenopausal women. Arch Osteoporos 10:1–7CrossRef
27.
Zurück zum Zitat Janssen JA, Burger H, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW, Pols HA (1998) Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138:627–632CrossRefPubMed Janssen JA, Burger H, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW, Pols HA (1998) Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138:627–632CrossRefPubMed
28.
Zurück zum Zitat Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257–4262PubMed Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83:4257–4262PubMed
29.
Zurück zum Zitat Johansson AG, Burman P, Westermark K, Ljunghall S (1992) The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 232:447–452CrossRefPubMed Johansson AG, Burman P, Westermark K, Ljunghall S (1992) The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 232:447–452CrossRefPubMed
30.
Zurück zum Zitat Munoz-Torres M, Mezquita-Raya P, Lopez-Rodriguez F, Torres-Vela E, de Dios Luna J, Escobar-Jimenez F (2001) The contribution of IGF-I to skeletal integrity in postmenopausal women. Clin Endocrinol 55:759–766CrossRef Munoz-Torres M, Mezquita-Raya P, Lopez-Rodriguez F, Torres-Vela E, de Dios Luna J, Escobar-Jimenez F (2001) The contribution of IGF-I to skeletal integrity in postmenopausal women. Clin Endocrinol 55:759–766CrossRef
31.
Zurück zum Zitat Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchia L, Pacitti MT, Mazzuoli G (1993) Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1–6CrossRefPubMed Romagnoli E, Minisola S, Carnevale V, Scarda A, Rosso R, Scarnecchia L, Pacitti MT, Mazzuoli G (1993) Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1–6CrossRefPubMed
32.
33.
Zurück zum Zitat Korkmaz U, Korkmaz N, Yazici S, Erkan M, Baki AE, Yazici M, Ozhan H, Ataoglu S (2012) Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women. Eur J Intern Med 23:154–158CrossRefPubMed Korkmaz U, Korkmaz N, Yazici S, Erkan M, Baki AE, Yazici M, Ozhan H, Ataoglu S (2012) Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women. Eur J Intern Med 23:154–158CrossRefPubMed
34.
Zurück zum Zitat Laudisio A, Marzetti E, Pagano F, Bernabei R, Zuccala G (2009) Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study. Clin Rheumatol 28:145–151CrossRefPubMed Laudisio A, Marzetti E, Pagano F, Bernabei R, Zuccala G (2009) Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study. Clin Rheumatol 28:145–151CrossRefPubMed
35.
Zurück zum Zitat Grzegorzewska AE, Mlot-Michalska M (2011) Bone mineral density, its predictors, and outcomes in peritoneal dialysis patients. Advances in peritoneal dialysis. Conf Perit Dial 27:140–145 Grzegorzewska AE, Mlot-Michalska M (2011) Bone mineral density, its predictors, and outcomes in peritoneal dialysis patients. Advances in peritoneal dialysis. Conf Perit Dial 27:140–145
36.
Zurück zum Zitat Cesari M, Pahor M, Lauretani F, Penninx BW, Bartali B, Russo R, Cherubini A, Woodman R, Bandinelli S, Guralnik JM, Ferrucci L (2005) Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos Int 16:691–699CrossRefPubMed Cesari M, Pahor M, Lauretani F, Penninx BW, Bartali B, Russo R, Cherubini A, Woodman R, Bandinelli S, Guralnik JM, Ferrucci L (2005) Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos Int 16:691–699CrossRefPubMed
37.
Zurück zum Zitat Kang KY, Hong YS, Park SH, Ju JH (2015) Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis. Semin Arthr Rheum 45:202–207CrossRef Kang KY, Hong YS, Park SH, Ju JH (2015) Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis. Semin Arthr Rheum 45:202–207CrossRef
38.
Zurück zum Zitat Bergman A, Qureshi AR, Haarhaus M, Lindholm B, Barany P, Heimburger O, Stenvinkel P, Anderstam B (2017) Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis. J Nephrol 30:255–262CrossRefPubMed Bergman A, Qureshi AR, Haarhaus M, Lindholm B, Barany P, Heimburger O, Stenvinkel P, Anderstam B (2017) Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis. J Nephrol 30:255–262CrossRefPubMed
39.
Zurück zum Zitat Chen H, Li J, Wang Q (2018) Associations between bone-alkaline phosphatase and bone mineral density in adults with and without diabetes. Medicine 97:e0432CrossRefPubMedCentralPubMed Chen H, Li J, Wang Q (2018) Associations between bone-alkaline phosphatase and bone mineral density in adults with and without diabetes. Medicine 97:e0432CrossRefPubMedCentralPubMed
40.
Zurück zum Zitat Zhang F, Xiao P, Yang F, Shen H, Xiong DH, Deng HY, Papasian CJ, Drees BM, Hamilton JJ, Recker RR, Deng HW (2008) A whole genome linkage scan for QTLs underlying peak bone mineral density. Osteoporos Int 19:303–310CrossRefPubMed Zhang F, Xiao P, Yang F, Shen H, Xiong DH, Deng HY, Papasian CJ, Drees BM, Hamilton JJ, Recker RR, Deng HW (2008) A whole genome linkage scan for QTLs underlying peak bone mineral density. Osteoporos Int 19:303–310CrossRefPubMed
41.
Zurück zum Zitat Hsu YH, Xu X, Terwedow HA, Niu T, Hong X, Wu D, Wang L, Brain JD, Bouxsein ML, Cummings SR (2010) Large-scale genome-wide linkage analysis for loci linked to BMD at different skeletal sites in extreme selected sibships. J Bone Miner Res 22:184–194CrossRef Hsu YH, Xu X, Terwedow HA, Niu T, Hong X, Wu D, Wang L, Brain JD, Bouxsein ML, Cummings SR (2010) Large-scale genome-wide linkage analysis for loci linked to BMD at different skeletal sites in extreme selected sibships. J Bone Miner Res 22:184–194CrossRef
42.
Zurück zum Zitat Xiao P, Shen H, Guo YF, Xiong DH, Liu YZ, Liu YJ, Zhao LJ, Long JR, Guo Y, Recker RR (2010) Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J Bone Miner Res 21:1536–1544CrossRef Xiao P, Shen H, Guo YF, Xiong DH, Liu YZ, Liu YJ, Zhao LJ, Long JR, Guo Y, Recker RR (2010) Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J Bone Miner Res 21:1536–1544CrossRef
Metadaten
Titel
Assessing the Genetic Correlations Between Blood Plasma Proteins and Osteoporosis: A Polygenic Risk Score Analysis
verfasst von
Xiao Liang
Yanan Du
Yan Wen
Li Liu
Ping Li
Yan Zhao
Miao Ding
Bolun Cheng
Shiqiang Cheng
Mei Ma
Lu Zhang
Hui Shen
Qing Tian
Xiong Guo
Feng Zhang
Hong-Wen Deng
Publikationsdatum
10.10.2018
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 2/2019
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-018-0483-4

Weitere Artikel der Ausgabe 2/2019

Calcified Tissue International 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.